Matches in Wikidata for { <http://www.wikidata.org/entity/Q88454093> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q88454093 description "article scientifique publié en 2018" @default.
- Q88454093 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q88454093 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88454093 description "scientific article published on 20 July 2018" @default.
- Q88454093 description "wetenschappelijk artikel" @default.
- Q88454093 description "наукова стаття, опублікована в липні 2018" @default.
- Q88454093 name "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 name "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 type Item @default.
- Q88454093 label "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 label "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 prefLabel "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 prefLabel "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 P1433 Q88454093-35277EC0-23B1-4A82-8043-18D2E448BF3A @default.
- Q88454093 P1476 Q88454093-D555348E-55A5-40BE-873F-EADDA2EFBE96 @default.
- Q88454093 P2093 Q88454093-2C49584B-3BFD-4761-816B-B4F7C84C8D0A @default.
- Q88454093 P2093 Q88454093-53E33A23-C0AF-42C8-BE85-AAD593AD6385 @default.
- Q88454093 P2093 Q88454093-5EA7513F-13BA-4C47-9209-A6233A254161 @default.
- Q88454093 P2093 Q88454093-7D62F789-480F-4803-A0A9-C25B682BDB5A @default.
- Q88454093 P304 Q88454093-8787CC1C-9153-4F4C-98AA-79813A85BFFF @default.
- Q88454093 P31 Q88454093-8B58E22B-2D66-4308-8BE9-8E452E49A32E @default.
- Q88454093 P356 Q88454093-487CB7F2-EBE2-4095-9FEA-47130C61E604 @default.
- Q88454093 P433 Q88454093-36662823-3EC2-4586-940C-99E600F03EAE @default.
- Q88454093 P478 Q88454093-861CF961-348C-47CD-9384-DCD26D77D9AB @default.
- Q88454093 P50 Q88454093-083D1C39-1761-47EC-A6EE-99F2F0E7F26F @default.
- Q88454093 P50 Q88454093-20217437-145B-454E-B3E4-E4E26CCDF415 @default.
- Q88454093 P50 Q88454093-30DFE690-CF5C-4F77-9E9B-627C5B25285D @default.
- Q88454093 P50 Q88454093-3778070A-7130-46BD-BBB6-286418BF1E11 @default.
- Q88454093 P50 Q88454093-39E6ED5A-3EB0-4CA1-BAE4-E2626A5A4CC8 @default.
- Q88454093 P50 Q88454093-6580309E-9FCD-4FE1-BA58-A493D82764AD @default.
- Q88454093 P50 Q88454093-70BCE371-DAA0-4949-B73C-D9A5AE4C8A4B @default.
- Q88454093 P50 Q88454093-94B077C2-0D3D-40BD-8C00-E11A3D855CDD @default.
- Q88454093 P50 Q88454093-AE92DFB8-C4DD-40CB-86C0-F629983F37F7 @default.
- Q88454093 P50 Q88454093-AEE0756D-ED5E-499E-BE86-4F2422E05882 @default.
- Q88454093 P50 Q88454093-B2D91A65-F1E9-491F-9CCD-AB83836C5C6B @default.
- Q88454093 P50 Q88454093-E855F98F-FB26-4798-8E6C-5C7D6BB0B3C6 @default.
- Q88454093 P50 Q88454093-F7D93397-92D8-455A-8997-0AB83D13CE46 @default.
- Q88454093 P577 Q88454093-697D4F00-2A82-4E9C-BAC0-013A81157560 @default.
- Q88454093 P698 Q88454093-C6BB91A6-9E78-4BEB-AE3D-670F84BBDE1F @default.
- Q88454093 P921 Q88454093-9ADED45F-4740-46BC-8B37-74E187B7714A @default.
- Q88454093 P356 EIJ-D-17-01152 @default.
- Q88454093 P698 29688175 @default.
- Q88454093 P1433 Q26842537 @default.
- Q88454093 P1476 "Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial" @default.
- Q88454093 P2093 "Ivo M van Dongen" @default.
- Q88454093 P2093 "Joelle Elias" @default.
- Q88454093 P2093 "Jose P S Henriques" @default.
- Q88454093 P2093 "Ruben Yannick G Tijssen" @default.
- Q88454093 P304 "e434-e442" @default.
- Q88454093 P31 Q13442814 @default.
- Q88454093 P356 "10.4244/EIJ-D-17-01152" @default.
- Q88454093 P433 "4" @default.
- Q88454093 P478 "14" @default.
- Q88454093 P50 Q101056967 @default.
- Q88454093 P50 Q110910888 @default.
- Q88454093 P50 Q114300816 @default.
- Q88454093 P50 Q114309602 @default.
- Q88454093 P50 Q57902235 @default.
- Q88454093 P50 Q63253317 @default.
- Q88454093 P50 Q87097227 @default.
- Q88454093 P50 Q87114420 @default.
- Q88454093 P50 Q88499761 @default.
- Q88454093 P50 Q92684782 @default.
- Q88454093 P50 Q92992824 @default.
- Q88454093 P50 Q96122455 @default.
- Q88454093 P50 Q98184705 @default.
- Q88454093 P577 "2018-07-20T00:00:00Z" @default.
- Q88454093 P698 "29688175" @default.
- Q88454093 P921 Q261327 @default.